Simon Cleall

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text

Medicine, Oncology, Pharmacology +11

Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

Michaëla Diamant, Michael A. Nauck, Rimma M. Shaginian et al. · Diabetes Care · 2014 · 222 citations

Medicine, Endocrinology, Pharmacotherapy +17

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2023 · 44 citations · Full text

Medicine, Oncology, Pharmacology +11

Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase <scp>IV</scp> trial

Francisco J. Tinahones, Jorge Luiz Gross, Adriana Onaca et al. · Diabetes Obesity and Metabolism · 2014 · 42 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Decision-making in a phase II clinical trial: a new approach combining Bayesian and frequentist concepts

Nigel Stallard, John Whitehead, Simon Cleall · Pharmaceutical Statistics · 2005 · 40 citations

Medicine, Biostatistics, Pharmacology +17